Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenyu Yan

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Blood|March 2, 2026
CDK8/CDK19 inhibition restores T-cell homeostasis in primary immune thrombocytopeniaYan-Ming Wang, Hu Zhou, Shaoqiu Leng, et al.
Nature Medicine|November 20, 2025
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trialsFeng Xue, Mankai Ju, Tienan Zhu, et al.
BMJ (Clinical Research Ed.)|October 21, 2025
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trialYunfei Chen, Yanmei Xu, Jiawen Dai, et al.
NPJ Digital Medicine|June 16, 2025
Alzheimer's disease digital biomarkers multidimensional landscape and AI model scoping reviewWenhao Qi, Xiaohong Zhu, Bin Wang, et al.
British Journal of Haematology|June 1, 2026
Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective studyLiQin Cao, Jin Wu, ZhuoYu An, et al.
Blood Science (Baltimore, Md.)|November 3, 2025
Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025)Feng Xue, Yu Hu, Renchi Yang, et al.
The Lancet. Haematology|June 17, 2024
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 studyYu Hu, Xiaofan Liu, Hu Zhou, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Blood|March 2, 2026
CDK8/CDK19 inhibition restores T-cell homeostasis in primary immune thrombocytopeniaYan-Ming Wang, Hu Zhou, Shaoqiu Leng, et al.
Nature Medicine|November 20, 2025
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trialsFeng Xue, Mankai Ju, Tienan Zhu, et al.
BMJ (Clinical Research Ed.)|October 21, 2025
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trialYunfei Chen, Yanmei Xu, Jiawen Dai, et al.
NPJ Digital Medicine|June 16, 2025
Alzheimer's disease digital biomarkers multidimensional landscape and AI model scoping reviewWenhao Qi, Xiaohong Zhu, Bin Wang, et al.
British Journal of Haematology|June 1, 2026
Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective studyLiQin Cao, Jin Wu, ZhuoYu An, et al.
Blood Science (Baltimore, Md.)|November 3, 2025
Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025)Feng Xue, Yu Hu, Renchi Yang, et al.
The Lancet. Haematology|June 17, 2024
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 studyYu Hu, Xiaofan Liu, Hu Zhou, et al.
Pageof 6